Market Cap 173.75M
Revenue (ttm) 61.86M
Net Income (ttm) -11.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 34.80
Profit Margin -18.48%
Debt to Equity Ratio 0.82
Volume 43,683
Avg Vol 297,008
Day's Range N/A - N/A
Shares Out 27.54M
Stochastic %K 69%
Beta 1.03
Analysts Strong Sell
Price Target $13.50

Company Profile

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 480 434 6670
Address:
9237 East Via de Ventura Blvd., Suite 105, Scottsdale, United States
buymoremakemore
buymoremakemore Jun. 4 at 4:19 PM
$DERM Found on rosacea reddit someone named "Budget-Objective8519" claims to work for Journey, and was recommending the coupon program to a new patient, saying along the lines that it is "potentially free with insurance or 35 dollar with copay". Information we know. Sounds like their sales team is working harder. Which is reasonable to justify the cost of the increase in headcount, and to maximize revenue until the next formulary updates happen later this year. They deleted their comment though. Gonna keep my eye out for future posts from them. It's also possible it's just someone pumping the stock, and didn't want to get caught saying something that was a lie.
1 · Reply
BobMacDTruck
BobMacDTruck Jun. 4 at 1:45 PM
$DERM WTF are they doing to expand E outside US? Why no applications or partners announcement?
1 · Reply
Sawnchey
Sawnchey Jun. 3 at 1:52 PM
$DERM Got my fill at 5.95 yesterday, really happy now with my position, now just looking forward to the next sales update!
0 · Reply
buymoremakemore
buymoremakemore Jun. 2 at 6:38 PM
$DERM Welcome new Emrosi patients. Not just for rosacea but off label perioral dermatitis. Onward and upward!!
1 · Reply
Tomasini
Tomasini Jun. 2 at 4:01 PM
$DERM entire small cap bio market been under a short attack. Without need, will continue. But it also creates buying opportunities. I am adding under $6
1 · Reply
gb11
gb11 Jun. 2 at 2:23 PM
$DERM Fundamental doesn't matter in this market at the moment. What matters is that who can draw more liquidity with bullish news and projections. This is a dead stock at the moment with 100 shares being traded every 5 minutes. The management is missing a huge oppotunity by not announcing anything in this kind of market.
0 · Reply
gb11
gb11 Jun. 2 at 2:07 PM
$DERM FFS make an announcement. anything.
0 · Reply
ValueBioTracker
ValueBioTracker Jun. 1 at 3:31 PM
$DERM Hope my 10k order at $6 gets filled
0 · Reply
ValueBioTracker
ValueBioTracker Jun. 1 at 9:50 AM
$DERM https://www.tiktok.com/@kyliethompson83/photo/7538451532942036279?is_from_webapp=1&sender_device=pc&web_id=7559704699549894155
0 · Reply
JFais
JFais May. 29 at 7:33 PM
1 · Reply
Latest News on DERM
Journey Medical reports Q1 EPS 2c vs. (4c) last year

2026-05-13T20:40:18.000Z - 21 days ago

Journey Medical reports Q1 EPS 2c vs. (4c) last year


Journey Medical Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 21 days ago

Journey Medical Earnings Call Transcript: Q1 2026


Journey Medical Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 21 days ago

Journey Medical Earnings release: Q1 2026


Journey Medical Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 21 days ago

Journey Medical Quarterly report: Q1 2026


Journey Medical Slides: Investor presentation

May 6, 2026, 7:00 AM EDT - 4 weeks ago

Journey Medical Slides: Investor presentation


Journey Medical Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Journey Medical Proxy statement: Proxy filing


Journey Medical Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Journey Medical Proxy statement: Proxy filing


Journey Medical Slides: Investor presentation

Apr 3, 2026, 7:00 AM EDT - 2 months ago

Journey Medical Slides: Investor presentation


Journey Medical price target raised to $12 from $11 at B. Riley

2026-03-26T12:51:06.000Z - 2 months ago

Journey Medical price target raised to $12 from $11 at B. Riley


Journey Medical reports FY25 EPS (47c) vs. (72c) last year

2026-03-25T22:20:17.000Z - 2 months ago

Journey Medical reports FY25 EPS (47c) vs. (72c) last year


Journey Medical Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 2 months ago

Journey Medical Earnings Call Transcript: Q4 2025


Journey Medical Annual report: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 2 months ago

Journey Medical Annual report: Q4 2025


Journey Medical Earnings release: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 2 months ago

Journey Medical Earnings release: Q4 2025


Journey Medical management to meet virtually with Lake Street

2026-02-18T16:15:21.000Z - 3 months ago

Journey Medical management to meet virtually with Lake Street


Journey Medical files $150M mixed securities shelf

2026-01-15T21:50:14.000Z - 4 months ago

Journey Medical files $150M mixed securities shelf


Journey Medical Registration statement: Registration Filing

Jan 15, 2026, 7:00 AM EST - 5 months ago

Journey Medical Registration statement: Registration Filing


Journey Medical announces results from Phase 1 trial of DFD-29

2025-12-10T13:50:12.000Z - 6 months ago

Journey Medical announces results from Phase 1 trial of DFD-29


Journey Medical Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

Journey Medical Earnings Call Transcript: Q3 2025


Journey Medical Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

Journey Medical Quarterly report: Q3 2025


Journey Medical Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

Journey Medical Earnings release: Q3 2025


Journey Medical reports Q3 EPS (9c), consensus (4c)

2025-11-12T21:12:01.000Z - 7 months ago

Journey Medical reports Q3 EPS (9c), consensus (4c)


Journey Medical initiated with a Buy at H.C. Wainwright

2025-08-25T10:05:18.000Z - 10 months ago

Journey Medical initiated with a Buy at H.C. Wainwright


Journey Medical Transcript: Emerging Growth Conference 85

Aug 20, 2025, 12:35 PM EDT - 10 months ago

Journey Medical Transcript: Emerging Growth Conference 85


Journey Medical Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Journey Medical Earnings Call Transcript: Q2 2025


Journey Medical Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Journey Medical Quarterly report: Q2 2025


Journey Medical Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Journey Medical Earnings release: Q2 2025


Journey Medical reports Q2 EPS (16c) vs. (17c) last year

2025-08-12T20:21:30.000Z - 10 months ago

Journey Medical reports Q2 EPS (16c) vs. (17c) last year


Journey Medical price target raised to $12 from $9 at B. Riley

2025-07-30T12:36:09.000Z - 11 months ago

Journey Medical price target raised to $12 from $9 at B. Riley


Journey Medical announces expanded payer coverage for Emrosi

2025-07-14T12:41:42.000Z - 11 months ago

Journey Medical announces expanded payer coverage for Emrosi


Journey Medical Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Earnings Call Transcript: Q1 2025


Journey Medical Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Quarterly report: Q1 2025


Journey Medical Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Earnings release: Q1 2025


Journey Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Journey Medical Proxy statement: Proxy Filing


Journey Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Journey Medical Proxy statement: Proxy Filing


Journey Medical Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Journey Medical Proxy statement: Proxy Filing


Journey Medical Earnings Call Transcript: Q4 2024

Mar 26, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Earnings Call Transcript: Q4 2024


Journey Medical Annual report: Q4 2024

Mar 26, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Annual report: Q4 2024


Journey Medical Earnings release: Q4 2024

Mar 26, 2025, 4:30 PM EDT - 1 year ago

Journey Medical Earnings release: Q4 2024


Journey Medical Transcript: Status Update

Feb 5, 2025, 4:30 PM EST - 1 year ago

Journey Medical Transcript: Status Update


Journey Medical Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Journey Medical Quarterly report: Q3 2024


Journey Medical Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Journey Medical Earnings release: Q3 2024


Journey Medical Transcript: FDA Announcement

Nov 4, 2024, 8:30 AM EST - 1 year ago

Journey Medical Transcript: FDA Announcement


Journey Medical Press release: FDA Announcement

Nov 4, 2024, 8:30 AM EST - 1 year ago

Journey Medical Press release: FDA Announcement


Journey Medical Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Journey Medical Earnings Call Transcript: Q2 2024


Journey Medical Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Journey Medical Quarterly report: Q2 2024


Journey Medical Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Journey Medical Earnings release: Q2 2024


Journey Medical Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Earnings Call Transcript: Q1 2024


Journey Medical Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Quarterly report: Q1 2024


Journey Medical Earnings release: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Earnings release: Q1 2024


Journey Medical Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Journey Medical Proxy statement: Proxy Filing


Journey Medical Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Journey Medical Proxy statement: Proxy Filing


Journey Medical Earnings Call Transcript: Q4 2023

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Earnings Call Transcript: Q4 2023


Journey Medical Annual report: Q4 2023

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Annual report: Q4 2023


Journey Medical Earnings release: Q4 2023

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Journey Medical Earnings release: Q4 2023


Journey Medical Transcript: Roth MKM 36th Annual ROTH Conference

Mar 18, 2024, 12:30 PM EDT - 2 years ago

Journey Medical Transcript: Roth MKM 36th Annual ROTH Conference


buymoremakemore
buymoremakemore Jun. 4 at 4:19 PM
$DERM Found on rosacea reddit someone named "Budget-Objective8519" claims to work for Journey, and was recommending the coupon program to a new patient, saying along the lines that it is "potentially free with insurance or 35 dollar with copay". Information we know. Sounds like their sales team is working harder. Which is reasonable to justify the cost of the increase in headcount, and to maximize revenue until the next formulary updates happen later this year. They deleted their comment though. Gonna keep my eye out for future posts from them. It's also possible it's just someone pumping the stock, and didn't want to get caught saying something that was a lie.
1 · Reply
BobMacDTruck
BobMacDTruck Jun. 4 at 1:45 PM
$DERM WTF are they doing to expand E outside US? Why no applications or partners announcement?
1 · Reply
Sawnchey
Sawnchey Jun. 3 at 1:52 PM
$DERM Got my fill at 5.95 yesterday, really happy now with my position, now just looking forward to the next sales update!
0 · Reply
buymoremakemore
buymoremakemore Jun. 2 at 6:38 PM
$DERM Welcome new Emrosi patients. Not just for rosacea but off label perioral dermatitis. Onward and upward!!
1 · Reply
Tomasini
Tomasini Jun. 2 at 4:01 PM
$DERM entire small cap bio market been under a short attack. Without need, will continue. But it also creates buying opportunities. I am adding under $6
1 · Reply
gb11
gb11 Jun. 2 at 2:23 PM
$DERM Fundamental doesn't matter in this market at the moment. What matters is that who can draw more liquidity with bullish news and projections. This is a dead stock at the moment with 100 shares being traded every 5 minutes. The management is missing a huge oppotunity by not announcing anything in this kind of market.
0 · Reply
gb11
gb11 Jun. 2 at 2:07 PM
$DERM FFS make an announcement. anything.
0 · Reply
ValueBioTracker
ValueBioTracker Jun. 1 at 3:31 PM
$DERM Hope my 10k order at $6 gets filled
0 · Reply
ValueBioTracker
ValueBioTracker Jun. 1 at 9:50 AM
$DERM https://www.tiktok.com/@kyliethompson83/photo/7538451532942036279?is_from_webapp=1&sender_device=pc&web_id=7559704699549894155
0 · Reply
JFais
JFais May. 29 at 7:33 PM
1 · Reply
JFais
JFais May. 28 at 7:09 PM
$DERM - curling up nicely, think it heads to $8+ soon
1 · Reply
ValueBioTracker
ValueBioTracker May. 28 at 6:06 PM
$DERM Little risk and highly likely to see +60% gain in 2.5 months
0 · Reply
Tomasini
Tomasini May. 28 at 3:19 PM
$DERM nothing but low volume shorting and penny flipping
2 · Reply
ValueBioTracker
ValueBioTracker May. 28 at 8:13 AM
$DERM Can anyone watch A.G.P.’s Healthcare Company Showcase conference? I tried to watch it on their site, but I’m getting the message: “You cannot register for this webinar.
1 · Reply
FinSUN
FinSUN May. 26 at 2:40 PM
$DERM when ?
0 · Reply
MightyPumperDuck
MightyPumperDuck May. 22 at 8:00 PM
$DERM $5.47 is the number. That's the gap fill. Not bearish, just technical. Each earnings is going to be higher from here. Scrips are climbing and pricing is adjusting higher.
1 · Reply
FinSUN
FinSUN May. 22 at 7:33 PM
0 · Reply
buymoremakemore
buymoremakemore May. 22 at 3:43 PM
$DERM Nice to see this hold $6 for an entire week!as price per prescription improves it will hold higher prices. Cant wait to trade at s multiple like many dermatology stocks.
1 · Reply
gb11
gb11 May. 22 at 3:31 PM
$DERM I am afraid shorting with low volume is back with no buyer in sight. Need to wait for next er which is months away for any positive price action. Frustrating price action is back.
1 · Reply
FinSUN
FinSUN May. 22 at 3:19 PM
$DERM wen 10 ?
1 · Reply
gb11
gb11 May. 22 at 2:23 PM
$DERM In this market fomo in semis and tech will make you more money than a fundamentally strong thesis in any other sector.
2 · Reply
flyinghollaender
flyinghollaender May. 20 at 9:31 PM
$DERM conference transcription: „very healthy balance sheet, good position, gross margin looking to increase, 2 additional potential products in second half, all indicators looking good for emrosi“ Sounding very confident for growth in the next months/quarters
0 · Reply